Webinar Date/Time: Thu, Nov 7, 2024 11:00 AM EDT
Learn how the core analytical workflow of characterizing charge isoforms can be streamlined.
Register Free: https://www.biopharminternational.com/bp_w/advancing-core-workflows
Event Overview:
Characterization of charge isoforms, whether in early product development or associated with licensure filings, is usually achieved through separate analytical techniques. Fraction collection via ion-exchange (IEX) liquid chromatography or iCE followed by mass spectrometry are typically used.
This webinar discusses opportunities to advance core platform technologies through a fully integrated icIEF-UV/MS workflow on the Intabio ZT system and how rapid post-translational modification (PTM) characterization of charge isoforms can be used to guide decisions during early development.
Key Learning Objectives:
Who Should Attend:
Speakers:
Kristen Nields, PhD
Principal Scientist
Johnson & Johnson Innovative Medicine
Xiaoping He
Principal Scientist
Pfizer
Register Free: https://www.biopharminternational.com/bp_w/advancing-core-workflows
British Patient Capital Invests £10 Million in Maxion Therapeutics, Part of Series A Financing Round
March 27th 2025The £10 million (US$13 million) investment is part of a larger £58 million (US$75 million) Series A financing round to be used for the development of Maxion Therapeutics’ preclinical lead program for treating inflammatory diseases.